Clinical Trials Logo

Submental Fat clinical trials

View clinical trials related to Submental Fat.

Filter by:

NCT ID: NCT03005717 Completed - Submental Fat Clinical Trials

Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat

Start date: December 22, 2016
Phase: Phase 2
Study type: Interventional

Study LIPO-202-CL-31 is a multi center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of LIPO-202 versus placebo on submental bulging due to subcutaneous fat. Approximately 150 participants of either gender who have a "Moderate Bulge" or "Large Bulge" in the submental fat (on Patient-Reported Submental Bulging Scale [PR-SBS] and Clinician-Reported Submental Bulging Scale [CR-SBS]) will be recruited for this study.

NCT ID: NCT02163902 Completed - Healthy Clinical Trials

Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Start date: December 2013
Phase: Phase 3
Study type: Interventional

The investigation of the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat.

NCT ID: NCT02159729 Completed - Healthy Clinical Trials

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Start date: February 2009
Phase: Phase 2
Study type: Interventional

This was a long-term follow-up study of participants who completed Kythera-sponsored trials of ATX-101 (06-03, 07-07, 09-15)